- NASDAQ: MRNA shares are set to jump to around $85, a record high.
- Moderna Inc reported progress in its COVID-19 vaccine efforts
- Broader stock markets are also on the rise in the hopes of a broad turnaround.
Moderna Inc. (MRNA) is trading around $87, the highest on record and above the previous peak in May. The company has been at the forefront of efforts to develop immunization for the disease that is gripping the world and is now benefiting from progress as the trial produces a "robust immune response".
MRNA Stock News
The prestigious New England Journal of Medicine reported details about Moderna's vaccine efforts. The Massachusetts-based pharmaceutical firm tested its candidate on 45 humans, which all showed a robust amount of antibodies – as much as four times the level seen in recovered coronavirus patients.
Moreover, side-effects were minimal among those that were tested, showing the vaccine is safe. There still is a long road to approving, producing, and administering a vaccine to the globe's population is still long. Moderna's next step is a broad test of 30,000 people.
Contrary to the previous publication – when Moderna only issued a press release – the publication by the highly regarded magazine is already applauded by the medical community.
It is essential to note that other efforts are in play, most notably cooperation between the University of Oxford and AstraZeneca.
The S/P 500 has turned positive for the year, boosted by the NASDAQ: MRNA news.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD clings to daily gains above 1.0650
EUR/USD gained traction and turned positive on the day above 1.0650. The improvement seen in risk mood following the earlier flight to safety weighs on the US Dollar ahead of the weekend and helps the pair push higher.
GBP/USD recovers toward 1.2450 after UK Retail Sales data
GBP/USD reversed its direction and advanced to the 1.2450 area after touching a fresh multi-month low below 1.2400 in the Asian session. The positive shift seen in risk mood on easing fears over a deepening Iran-Israel conflict supports the pair.
Gold holds steady at around $2,380 following earlier spike
Gold stabilized near $2,380 after spiking above $2,400 with the immediate reaction to reports of Israel striking Iran. Meanwhile, the pullback seen in the US Treasury bond yields helps XAU/USD hold its ground.
Bitcoin Weekly Forecast: BTC post-halving rally could be partially priced in Premium
Bitcoin price shows no signs of directional bias while it holds above $60,000. The fourth BTC halving is partially priced in, according to Deutsche Bank’s research.
Week ahead – US GDP and BoJ decision on top of next week’s agenda
US GDP, core PCE and PMIs the next tests for the Dollar. Investors await BoJ for guidance about next rate hike. EU and UK PMIs, as well as Australian CPIs also on tap.